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 30  2 &,* *> * .E DNA	 
  *C*b d+ $,63-56 ), 2   ,*L D $ 30  .E
> 72 ), 2   ,*L D $ 30  > .E25 I*T  6$  O 
95 ),  2  ,*L D $ 30 	.E +d  *C*b55  ), 
2  ,*L D $ 30 > .E 72 ), .2  ,*9 D $ 30  .E
  5 , ( 52 B.A, 72 ), 2   ,*L\ &b.  
,  X> *PCR 	5/0  *2.8>*7.$   * *C*b   
)10 S$7.b(  )*   TAGC 	HC, * ,> 
  &W 1\ &>' &*	( 5/0 ) *2.8>*7.$10 /.$ S$ (  
mix Deoxy nucleotide triphosphate )dNTP ()*    
KBC &*( 	1  *2.8>*7.$ MgCl2 )50 /.$ S$ ()* 
  KBC &*( 	1/0  *2.8>*7.$ g5' Taq  *C./b  
)5  (*2.8>*7.$/ >)*   KBC  &*(  >2   *2.8>*7.$ 
DNA  ( g   *UB$ `'      ,-2 .$W   
25  *2.8>*7.$   .  
  
 2 	
  .DFNB48  
	 	   F )Forward(   R )Reverse(  
  




D15S1027 CTGAAAACCAGCCCACTC  GAGTCCCTGGAGAGCCC  196  66   
D15S984  GCAGACACGCTCGCAT  GAGGCTCCGAGGGCAG  220  92   
D15S1023  GGTATTGTTTTGGACCACATCTTAG  GGGAGGCTGAGACAGTTTC 272  86   
D15S973  ATCCACCTGACTCAAGGA  TTCTCCATCAGTAAATTGCG  250  67   
D15S114  AGAATGAGCAGCACTGTTTG  TTGTCACTGCTTTTCTCT  177  70   
D15S991  AGCTTGGTGACTCTATCAGGGTG  AACTGGCTGGTCTCTATTATCTGCG  
198  62   
D15S1001  TGGGCCTTGTGATTTTAG CATCTGTGTGTCTGTGACTG 259  53   
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w7+   O.*  *N ,$ DOUA  t>PCRC 	  > *  
/b dW '*6 $'.   *)  Merck &C8'	 * ,>    
 K  &* (12-8  &*)  	 Z,40  /.$ *$' D $   
5-4  u *B D*2.  h >   \>*278  > 5.$'
   3$  ,*L . *93 &, D9C  C. ,*\ ,	 
3   $ 92.b ,)> &' > g8 ,*\ , >    
C &3 92.b   , $ D9>*2 DZ  .  
 V$ * SLink  FastSlink version 2.51  * >
V$ *C   LOD )LOD score(  UB >, *2$b  T > 
UB 	   K.+*+ Superlink version 1.6  >  
Simwalk version 2.91 ,-2   )15 .(g l+/b 
)C$ >$ *93 l.+W ( ,I ,$ ,  
  92.b  H73$ ,-2 !*  5\Haplopainter version 2.95 
 92.b ,   .J+ N$  /*$ 1 .\*L DZ ,-2




90  Z,  >,  	* ,$ .OC) , O8U$ ,$ ,*\ 
\*  -  2,  .C  +     . ,85   Z,
,I * ,$ 	  >    ,  >3I k>, 6 
 ,,  )+  $*  |+* Q 	$.* $   &,  >
98 $>+ `/a$ s+ + ,$J.   t .,SLINK  1
,I  1. 7-2    ,>'* . ,60 ,I   O8U$ ,$	 
hb    >, *7+  > R8 * *93 98 * 
/b dW > * \>*278 *23. ,I *  .$' 6*'  , 
 tSLINK *+S	    , 92.b)7 61 .(  
  
  
 1 .      D15S984   ! "# 	$% 
&$ .'(  1 )2  3  +,	  %- 
$ ., ./,0, )( 

, 1%2 )1  2 % 2  3 (, 5 /,/ ./ 26 
#) /,0, 7
 &8 5!  26 1%2  +(    
/,0, (  26 1(%2 & 9. 
 ,, &3 92.b 98 *93 I* 28	  ( , $	 
+/b g &C l  67 ,  2  $  , , 98 	
R8  92.b  DFNB40  >DFNB48 +J 3  ..  
  
  
 2.  "# -%  :& ;%'/,< 1, % / # +=  
 "# 
, # 26 / . /& % 5,( ;% 
  5>% 
$ / 26. ' ?%, / 5,( & 15 )18  20) 
 "#	
  #  , >% ;% DFNB48 & / ./ 
C  "D& ,   !&  .  
  
$%  
O8U$ 1 ,	 60  &2   ,*\ >, 6A   ,I 
( 	& C9 /. > (T >  C *  .2@ > dV$	  *N 
 R8  92.b  DFNB40  >DFNB48    * .
 o  1 ! O8U$	  , R8 >, 1 c. 1..O+
,I  ,$ , * .O8U$ 1 ,	  ,I   . 
R8   ,  &3 92.b * ,$ .  
 R8DFNB40	  BC8, |+ *   &7C >   
400  *93 3B 3  92.bABI Prism  ,I  , 
  P3 $>+ `/a$ $  *.Q   i2$ *. 
. , ,)$ &W 1 T 	h     8+ 1..O+ *N ,$. 
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 0% 1 
 &W6$ > TBX1 ), !  ,  W  *.L, k*)  
$ !  1  &i2$  I* ,  ?B 6$ >  (  ,
 1  * ,Ie &>5L ,        &W 1	  3()
 3 \ .1.GC	 X()  &W DGCR6 ) &W6  BU$  /Z
, !  k*) ($ &. /I, tL ,   &W > ,CRYBB1 
&W) B 1.82* B1 (   , >    2)     1
&W  5.  3 \ 3() .1.GC	 74 ,I    i2$
ARSNHL  6./V+ > 5+ V+ &7C > BC8, |+
2.b R8 7.2W 9DFNB40   ,$   2\*L *A
 92.b &' ,  3 \)11.(  
Riazuddin > &7C  O8U$ 	 4  &W , P/2@$ X()
CIB2  2\.  ,54 ,I    2bARNSHL 	 
 59)c.272T>C  &W , D9CCIB2    ,* 
 59) {91 ' 1*  1.S' 6.\ O .$'  . 1.$ 
)F91S( ,8,    1.8> ,   z- D    ..$'
1.$,  8+EF-hand $ ,. , 2 ,I  .*+   
ARNSHL 	59)  c.297C>G  &W , D9CCIB2 
  59) {   99 ' O .$'  . 1.$ 1.y2.
&\2*+  )C99W( 8, ,     z- D    ..$'
$ , .X() 6$ &W 137-*+  F91S > C99W  ,
d/  COS-7  +CIB2 ./  X ,  g B8
|+   Adenosine triphosphate )ATP ( B$ , d/ 
$ X 3> c     , $ 1.   ,* . ,I  , 
.*+   ARNSHL	   59) c.368T>C  , D9C
 &WCIB2  8, 59) {       ..$'
C  123 1.*+  1.8>5 O )I123T (  9) ,
   z- D , 1.$,  8+EF-hand $ !>, , .
 X() > &W 137-*+1123T	  + CIB2  X , 
g./  |+   B8 ATP  d/ 	  c  B$ ,
3>	 $ X5\  , .2\ 1 $ ,(3.b  X()     > 
 g./  d+CIB2  + &' *\ .8O\ J $ *.E &3 > ,}L
$  1 & B\   ,&W	  g./ g.N+ , ?B K)$  
$ , )13.(  
,I  ,   *' !   x5  >3I c IJ  
 |+  .*+Ahmed  &7C > ,I &  PKDF117 
,   t5L )17 	( 59)  c.192G>C  , D9C
 &WCIB2    3$  59) { 64 ' .$'  . 1.$ O 
D$+/L  ) D+'E64D (A ,   $  z- D  
$    . d/ , X() 137-*+  COS-7  +CIB2 
 g./  X ,   |+   B8 ATP  , d/ 
,, X D   3> c  B$ )13 .(  
 O8U$ , 	ZiI    *r	  R8 >,   .
DFNB40  >DFNB48 ,I ,  &3 92.b * ,$ 
 , .  +  1  )+   &() FB * > &* , &
, 2\*L DZ   DO8U$ R8 >, 1   * 	
R8 1 *23. .OC) ,   3$  J  .\*a) > ,m
$ *N  >*r D>-2$  R8 1 XB &2 +   ,  
 ,* 1..O+  , .  ) &'  R8 , F*$ &W 
DFNB40  3  >*$  +  () *23. DO8U$ 	
 . &W 1 P3. *9, o* 	  R8 XB  )+ 
DFNB48  ,ARNSHL  *' !  , 1.GC >	  R8 1
$ 5L  +   C. >, * , X>mb * $  . 1.T
 $ +O8U$+  *.9C3T     ,  \*3.b  d*Q *L
 , .OC)  $, , > *  >3$   8Z .2W
g.( .   
.2 *.L (   1$ dC2  ,>R8  DFNB40 
 >DFNB48  .OC) ,  , , C XB  
,   * >   2 ,$ .OC) ,  /Z 6.8,
O8U$	 $ R8 *  F*$  +     , *.L,. 
d 1 	 .A, XB 1..O+ * R8 1 *+    &$3 ,
,I , O+ > DO8U$ *23.   ..  
  
"&  '(  
 8B$ 1 2\*L* &b %2  $  & Cb gN  C 
*L 1497 $  .  75b !/ 93, 3>mb >O$ 
 + () 	,**(J DB.BV+ 5*$ & 1.GC > ), 1.$
 1 ,  $  ,**( 75b !/ 93, 878$ > 8/
 *73+ > * B+ dC 	 ,C  X>mb$ 6C  ' .  	1.GC
 ,I >  &C.  1 ! ,  &3  X>mb 
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Abstract 
Background: Sensorineural hearing loss (SNHL) is the most common sensory disorder and 1 in every 500-1000 newborns 
is affected. Non-syndromic SNHL accounts for 70% of hereditary hearing loss and 80% of SNHL cases have an 
autosomal recessive mode of inheritance (ARNSHL). The Purpose of the recent study is genetic linkage analysis 
to determine the prevalence of DFNB40 and DFNB48 loci in studying families with ARNSHL from the western 
provinces of Iran.  
Methods: In this study, 60 families from 3 provinces of Iran involving Hamedan, Kohgiluyeh and Boyer-Ahmad 
and Chaharmahal and Bakhtiari with autosomal recessive non syndromic hearing loss were examined. The 
selected families in this study were consanguineous and had at least two patients. They also were negative for 
GJB2 mutations. Linkage analysis was performed by using 6 markers short tandem repeat (STR) for the 
DFNB40 locus and 7 markers STR for the DFNB48 locus. 
Findings: After examining different families, it was revealed that none of them showed linkage to the DFNB40 
and DFNB48 loci. 
Conclusion: The recent study suggests that DFNB40 and DFNB48 loci might not play an important role in 
causing hearing loss in the mentioned provinces. However, further studies are necessary to determine more 
precisely the role of these loci in the Iranian population. 
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